+44 20 45 77 39 61 | 09:00 - 17:00 | Mon/Fri
Access the Alternative Investments Platform of the Future.
We make life easier for institutional investors by equipping your team with everything needed to drive growth. Say goodbye to spending hundreds of hours on due diligence, relying on warm introductions, attending endless events, or second-guessing trustworthiness—we handle it all and more, at no cost to your team.
Private companies
Executive Summary
Financial Modeling
Financial Statements & Ratios
Decks
Founders Video
Capitalization Table
Background Checks
AI Matching Tool
Mostly Off-Market with Lead Investor
We are investment banking and alternative investment professionals. Our main focus is on emerging industries, crisis-alpha mandates, and quantitative-driven investments. We have a special touch for impact, AI, fintech, healthcare, quantitative hedge funds, urban development, and agritech.
Industries
Closed-end funds
Executive Summary
PPM (Private Placement Memorandums)
DDQ (Due Diligence Questionary)
LPAs (Limited Partners Agreement)
Subscription Agreement
Operating Company Agreement
Decks
Capitalization Table
AI Matching Tool
Financial Statements & Ratios
Founders Video
Mostly Off-Market with Lead Investor
Invest for Impact.
Some of Our Current Mandates
Green-Tech Brand Raising €5M
A green-tech brand generating €5M in revenue aims to reach €20M by 2025 and €55M by 2026. With access to over 50 million hectares through Bayer CropScience and major projects like NEOM's 156 million square meters, the company is raising €5M to expand globally across urban and agricultural sectors, driving sustainable growth.
USDA Organic Supplement Brand
USDA Organic supplement brand with doubled growth year-over-year, reaching $2M in revenue in 2024 with $500K net income and 65% gross margins. With nationwide expansion into 650 Vitamin Shoppe locations set for early 2025, the company is raising a seed round to fuel marketing, product launches, and retail growth.
An AI-driven tool for e-commerce optimization is on track for $500K ARR by May, with over 1 million users and key clients like 1-800 Flowers and Ashley Furniture. With 16 trial customers expected to convert at 70%, the company is raising $5M at a $20M valuation to scale its reach in the growing AI-powered SEO market.
AI E-commerce Company Raising $5M
Mobile Operator Raising $3M
A profitable Mobile Virtual Network Operator (MVNO) offers wireless internet to RVs and underserved rural households, with $6.1M ARR in 2024 and 100% YoY growth. Utilizing multi-carrier coverage from Verizon, AT&T, and T-Mobile, the user-friendly “SIM-less” router ensures easy connectivity. The company targets a $94 billion market with 52 million potential customers, including 43 million rural households and 11 million RV owners.
Fintech Company Raising $3M
A fintech company is reinventing envelope budgeting by authorizing transactions in real time based on user budgets. It is growing 16-20% monthly, adding over 500 subscriptions in May, and nearing TRUE profitability with a projected $2M ARR in 2024. The company is raising $2-3 million to boost growth through marketing and team expansion, with angel funds already secured.
The first AI platform that autonomously generates complex business-grade software from simple prompts, cutting development costs by up to 90%. With partnerships in place, including a top European pharma company, it has onboarded 10 new clients in August alone. Projected revenue exceeds $30M by 2025 with over 90% gross margins. Raising its seed round to meet the growing demand for AI-driven software development.
AI Company Raising $10M
Biotech Brand Raising $5M
A biotech company is pioneering psilocybin-based therapies for eating disorders, with its lead product entering Phase 2 clinical trials. The proprietary formulation offers minimal side effects, addressing a market lacking effective treatments. With a strategic partnership for low-cost production and experienced leadership, the company is raising $5M to fund these crucial trials, positioning itself for significant valuation growth.
Biotech Brand Raising $5M
A biotech wellness brand has launched the first legal psychedelic micro-dose product, achieving 100% YoY growth with over 3,000 active customers and 85% gross margins. Positioned in the $34.4B functional mushroom and $4.8B psychedelic therapy markets, the company is backed by leading neuroscientists. Raising $5M to accelerate expansion in natural health and mental wellness.
An innovative wellness center offers IV therapy, peptide therapy, weight loss solutions, and biomarker testing, all under nurse-led supervision. $2M in revenue from its first location and a second location expected to generate $3.5M annually; self-funded and profitable. Forecasted revenue of $27M by 2026. Raising $4M to expand operations and franchise, positioning itself within the $5.6 trillion wellness market.
4o mini
Wellness Center Raising $4M
Create An Account
Address
128 City Road, London, EC1V 2NX, United Kingdom
Contact
+44 20 45 77 39 61 / contact@orgonbank.com
By accessing and using this website, you acknowledge and agree to our Compliance Disclaimer, Use of Cookies, Risk Disclaimer, Terms and Conditions, and Privacy Policy. If you are not a Qualified Institutional Buyer (QIB) or institutional investor, please refrain from using this website.
Orgon Systems SWF LTD, a British holding company registered under number 15145224 and based at 128 City Road, London, EC1V 2NX, United Kingdom, operates solely as a Placement Agent and Venture Builder. Under the Orgon Bank brand, Orgon Systems SWF LTD engages in two primary business verticals:
Boutique Placement Agency: Orgon Systems SWF LTD exclusively acts as a Placement Agent, providing capital-raising introductions between QIBs and alternative investment providers such as private companies and closed-end funds outside the United Kingdom. Orgon Bank DOES NOT offer financial services. The term "bank" refers only to our role in capital introductions within the investment banking sector. We are not a commercial bank and do not offer regulated financial services, such as investment advisory, financial planning, commercial banking, lending, or asset management. We do not hold client funds or provide financial intermediation services.
Venture Factory: In this vertical, we focus on developing and incubating ventures specifically for the benefit of our shareholders. We do not launch businesses on behalf of external corporate clients.
Orgon Systems SWF LTD is dedicated to strict regulatory compliance and works closely with regulatory authorities to ensure adherence to applicable laws. Our sole purpose in this context is Capital Introductions, and we do NOT offer investment management, financial advisory, or any form of regulated financial services.
For more information on what a placement agent is, the fundamentals of alternative investments, or insights into the alternative investments and investment banking industry, please refer to our FAQ page.
The content on this website is for informational purposes only and does not constitute an offer to buy or sell, or a solicitation to offer or sell, any securities in jurisdictions where such actions are unauthorized. The content here is not financial, legal, accounting, or tax advice and should not be relied upon as such. This website and its contents are not an offer or invitation to U.S. Persons to purchase or subscribe to any securities, nor a solicitation of any offer to sell securities to U.S. Persons.
Please direct any compliance inquiries to compliance@orgonbank.com.
Trademarks Notice: CAIA Association, CFA Institute, ILPA, The Power MBA, CMT Association, and Corporate Finance Institute are trademarks of their respective organizations. Orgon Systems SWF LTD is independent of these organizations and adheres only to their educational standards. We do NOT have a partnership with them.
All Investment Banking Services | Privacy policy | Terms and conditions | Legal notice | Contact us | Orgon Bank Group | Careers | Sustainability